Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice

Among biological agents for the treatment of atopic dermatitis (AD), dupilumab is a front-runner. Although many studies have been conducted on the real-world use of dupilumab, the sample size is often small and data is primarily on Western people. Therefore, we investigated the efficacy and safety o...

Full description

Bibliographic Details
Main Authors: Dong Hyek Jang, Seok Jae Heo, Hye Jung Jung, Mi Yeon Park, Seong Jun Seo, Jiyoung Ahn
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
atopic dermatitis
dupilumab
Patient Oriented Eczema Measure (POEM)
female gender
lactate dehydrogenase (LDH)
eosinophilia
Online Access:https://www.mdpi.com/2077-0383/9/6/1982

Internet

https://www.mdpi.com/2077-0383/9/6/1982

Similar Items